Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aptus PharmaBOM:544529 +3.34%18 Days Inventory is 140.38 as of Mar. 2026, which is 2% below its 10-year median of 142.69. GuruFocus rates BOM:544529 with a GF Score™ of 18/100. The stock has 6 warning signs investors should review. Among 117 Medical Distribution companies, Aptus Pharma ranks worse than 90.6% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Aptus Pharma's Average Total Inventories for the
six
months ended in Mar. 2026 was ₹119.6 Mil. Aptus Pharma's Cost of Goods Sold for the
six
months ended in Mar. 2026 was ₹155.5 Mil.
Hence, Aptus Pharma's Days Inventory for the
six
months ended in Mar. 2026 was 140.38.
The historical rank and industry rank for Aptus Pharma's Days Inventory or its related term are showing as below:
BOM:544529'
s Days Inventory Range Over the Past 10 Years
Min: 104.52 Med: 142.69 Max: 211.72
Current: 176.37
During the past 4 years, Aptus Pharma's highest Days Inventory was 211.72. The lowest was 104.52. And the median was 142.69.
BOM:544529's Days Inventory is ranked worse than 90.6% of 117
companies
in the Medical Distribution industry
Industry Median: 57.73
vs BOM:544529: 176.37
Aptus Pharma's Days Inventory
declined
from Mar. 2025 (241.24) to Mar. 2026 (140.38).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Aptus Pharma's Inventory Turnover for the
six
months ended in Mar. 2026 was 1.30.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Aptus Pharma's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.37.
Aptus Pharma (BOM:544529) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Aptus Pharma's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Aptus Pharma's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Aptus Pharma Days Inventory Related Terms
Aptus Pharma Days Inventory Historical Data
* Premium members only.
The historical data trend for Aptus Pharma's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544529 vs MCK, COR, CAH: Days Inventory Comparison
For the Medical Distribution subindustry, Aptus Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aptus Pharma Days Inventory vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Aptus Pharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where Aptus Pharma's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aptus Pharma (BOM:544529) has a Days Inventory of 140.38 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Aptus Pharma and its competitors. This is near median its historical median of 142.69. Over the past decade, Aptus Pharma's Days Inventory has ranged from 104.52 to 211.72. According to the industry distribution chart, Aptus Pharma ranks #106 out of 117 companies in the Medical Distribution industry, placing it in the top 90.6%.
Is Aptus Pharma's Days Inventory too high?
Aptus Pharma's current Days Inventory of 140.38 is near median its 10-year median of 142.69. Over the past 10 years, this metric has ranged from a low of 104.52 to a high of 211.72. The Medical Distribution industry median Days Inventory is 57.73. Aptus Pharma's value of 140.38 is 143.2% above this industry median. Based on the distribution chart, Aptus Pharma ranks #106 out of 117 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Aptus Pharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Aptus Pharma's Days Inventory compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Aptus Pharma ranks #106 out of 117 companies for Days Inventory. This places Aptus Pharma in the lower half of its industry. The industry median Days Inventory is 57.73. Aptus Pharma's value of 140.38 is 143.2% above this benchmark. Historically, Aptus Pharma's own Days Inventory has ranged from 104.52 to 211.72 over the past decade. While the company's 10-year median is 142.69 vs. the industry median of 57.73, Aptus Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Distribution company?
The median Days Inventory among Medical Distribution companies is 57.73, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aptus Pharma's current Days Inventory of 140.38 is 143.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Aptus Pharma and its competitors. For the Medical Distribution industry, the median Days Inventory is 57.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aptus Pharma's current Days Inventory is 140.38, which is near median its own 10-year median of 142.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aptus Pharma stock overvalued right now?
Aptus Pharma (BOM:544529) has a current Days Inventory of 140.38. The current Days Inventory is 140.38, which is near median its 10-year median of 142.69 and 143.2% above the Medical Distribution industry median of 57.73. Aptus Pharma's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Aptus Pharma (BOM:544529), the current Days Inventory is 140.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations. It operates through a contract manufacturing model. The group provides a diverse range of pharmaceutical products catering to various therapeutic categories, including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.
18GF Score
Get the complete analysis for BOM:544529
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544529 has been successfully added to your 
